Altimmune, Inc.: Company Events Publications and Financial Calendar | ALT | US02155H2004

Chart calendar Altimmune, Inc.

58.ARxPXai6VsDcAmPVHI_yBcyC_qwfa_PcDiqqoq6Fo9g.UVolHPDsbvCsYxLjZve_YovRj8VAKLyYf0zP1e3TwuxJRCMZmvxk97h2Vw~9049f6dd3356158f4a6dfb543ac1ceda

Upcoming events on Altimmune, Inc.

2026-03-25	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-05-18	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-08-05	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-11-09	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Altimmune, Inc.

2025-12-03	Piper Sandler Healthcare Conference
2025-11-20	Jefferies Global Healthcare Conference
2025-11-12	Stifel Healthcare Conference
2025-11-11	American Association for the Study of Liver Diseases Meeting - Dr. Mazen Noureddin
2025-11-08	American Association for the Study of Liver Diseases Meeting - Dr. Julio Gutierrez
2025-11-06	Q3 2025 Earnings Call
2025-11-06	Q3 2025 Earnings Release
2025-10-21	H.C. Wainwright Liver Disease Virtual Conference
2025-09-30	Stifel Virtual Cardiometabolic Forum
2025-09-10	Morgan Stanley Global Healthcare Conference
2025-09-09	H.C. Wainwright Global Investment Conference
2025-09-04	Wells Fargo Healthcare Conference
2025-08-12	Q2 2025 Earnings Call
2025-08-12	Q2 2025 Earnings Release
2025-06-26	Pemvidutide IMPACT Phase 2b Trial Results Call
2025-06-22	American Diabetes Association Scientific Conference
2025-06-22	American Diabetes Association Scientific Conference - Shaheen Tomah
2025-06-22	American Diabetes Association Scientific Conference - Poster No:778-P
2025-06-21	American Diabetes Association Scientific Conference - John J. Suschak
2025-06-21	American Diabetes Association Scientific Conference - Clinical Trials Testing Incretin-Based Therapi

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	-0,07 0,05 -241.67%	0,43 0,34 24.04%	0,02 0,00 541.03%	0,00	0,00	20,7
EBITDA Million USD	Released Forecast Spread	-87,9 -89,3 1.53%	-95,5 -83,1 -14.86%	-103 -101 -1.7%	-89,9	-118	-134
EBIT Million USD	Released Forecast Spread	-87,7 -91,4 3.99%	-83,5 -93,9 11.09%	-103 -104 0.71%	-90,2	-126	-130
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-84,9 -91,2 6.88%	-88,4 -81,2 -8.96%	-95,1 -95,7 0.64%	-85,4	-123	-124
Net income Million USD	Released Forecast Spread	-84,7 -90,9 6.82%	-88,4 -81,1 -9.1%	-95,1 -95,7 0.64%	-84,4	-123	-124
EPS USD	Released Forecast Spread	-1,81 -2,04 11.09%	-1,66 -1,47 -13.18%	-1,34 -1,34 0.11%	-0,99	-1,30	-1,06
Announcement Date		28/02/23	27/03/24	27/02/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	0,01 0,00 -	0,01 0,00 706.45%	0,01 0,00 706.45%	0,01 0,00 -	0,01 0,00 792.86%	0,01 0,00 792.86%	0,01 0,00 792.86%	0,00	0,00	0,00	0,00	0,00
EBITDA Million USD	Released Forecast Spread	-26,7 -21,8 -22.42%	-26,7 -19,9 -34.09%	-24,7 -20,4 -21.23%	-24,8 -23,0 -7.94%	-21,8 -26,6 18.08%	-22,9 -27,5 16.66%	-20,8 -23,5 11.41%	-24,4	-28,1	-30,9	-31,0
EBIT Million USD	Released Forecast Spread	-26,8 -23,7 -13.28%	-26,7 -25,2 -5.99%	-24,8 -26,4 6.03%	-24,9 -25,3 1.82%	-21,8 -27,4 20.35%	-22,9 -27,1 15.38%	-20,9 -25,5 18.07%	-24,6	-28,7	-32,5	-35,5	-40,8
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-24,4 -22,9 -6.37%	-24,6 -24,2 -1.94%	-22,8 -25,4 10.03%	-23,2 -24,1 3.66%	-20,3 -26,1 22.34%	-22,1 -25,6 13.64%	-19,0 -24,8 23.4%	-23,7	-26,5	-29,8	-33,8	-39,2
Net income Million USD	Released Forecast Spread	-24,4 -22,8 -7.1%	-24,6 -24,8 0.55%	-22,8 -25,7 10.96%	-23,2 -24,1 3.66%	-19,6 -26,1 24.95%	-22,1 -25,6 13.64%	-19,0 -22,7 16.25%	-23,3	-26,5	-29,8	-33,8	-39,2
EPS USD	Released Forecast Spread	-0,34 -0,36 5.99%	-0,35 -0,35 -1.45%	-0,32 -0,36 10.85%	-0,33 -0,33 0.4%	-0,26 -0,35 24.69%	-0,27 -0,31 13.4%	-0,21 -0,26 20.11%	-0,25	-0,28	-0,29	-0,32	-0,35
Announcement Date		09/05/24	08/08/24	12/11/24	27/02/25	13/05/25	12/08/25	06/11/25	-	-	-	-	-

Upcoming sector events for Altimmune, Inc.

2025-12-14	SANBIO COMPANY LIMITED	Q3 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-14	BIOCON LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-04	GENMAB A/S	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-04	ANAVEX LIFE SCIENCES CORP.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-09	EXELIXIS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-09	ARROWHEAD PHARMACEUTICALS, INC.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-10	VIKING THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-10	REZOLUTE, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-11	AGIOS PHARMACEUTICALS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-11	PROTHENA CORPORATION PLC	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Altimmune, Inc.

2025-12-05	PHARMAESSENTIA CORPORATION	November 2025 Sales and Revenue Release
2025-12-05	TAIMED BIOLOGICS INC.	November 2025 Sales and Revenue Release
2025-12-04	MAPLIGHT THERAPEUTICS, INC.	Q3 2025 Earnings Release
2025-12-03	KALVISTA PHARMACEUTICALS, INC.	Q2 2026 Earnings Release (Projected)
2025-11-25	ARROWHEAD PHARMACEUTICALS, INC.	Q4 2025 Earnings Release
2025-11-21	INVENTIVA	Q3 2025 Sales and Revenue Release
2025-11-17	IMMATICS N.V.	Q3 2025 Earnings Release
2025-11-14	SCHOLAR ROCK HOLDING CORPORATION	Q3 2025 Earnings Release
2025-11-13	ORUM THERAPEUTICS, INC.	Q3 2025 Earnings Release
2025-11-13	D&D PHARMATECH INC.	Q3 2025 Earnings Release